CDC Offers Grand Rounds on Unsafe Injection Practices
Grand Rounds at the Centers for Disease Control and Prevention (CDC) are a forum in which experts present a series of lectures and bring ideas from diverse perspectives on a public health issue.
The Grand Rounds, "Unsafe Injection Practices in the U.S. Healthcare System" will be held on Tuesday, Nov. 13, 2012 from 1 p.m. to 2 p.m. ET.
The Public Health Grand Rounds is a monthly webcast created to foster discussion on major public health issues. Each session focuses on key challenges related to a specific health topic, and explores cutting-edge scientific evidence and potential impact of different interventions. The Grand Rounds sessions also highlight how CDC and its partners are already addressing these challenges and discuss the recommendations for future research and practice.
Injectable medicines are commonly used in healthcare settings for the prevention, diagnosis, and treatment of various illnesses. This session of Grand Rounds will explore how unsafe injection practices that put patients at risk of infection have been associated with a wide variety of procedures and settings.
Unsafe injections also increase the burden on patients, healthcare providers, and medical care and public health systems. These harms are preventable through renewed attention to infection control and injection safety practices, which will be a focus of the presentations at this Grand Rounds.
CLICK HERE for a copy of the injection safety checklist that will be discussed at the upcoming Grand Rounds. For more information, CLICK HERE.
Â
Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
